반응 #1951427

ord-1e225f060d7b42d0b420b132f00941b1

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타obtained
  2. 2
    기타as described for the R-antipode in Example 2.3, preparation of starting materials)

실험 절차

The procedure described in Example 1 was repeated using N,N-dimethylglycine and N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-5-[(1S)-1-methyl-2-(methylamino)ethoxy]quinazolin-4-amine (obtained as described for the R-antipode in Example 2.3, preparation of starting materials) to give the title compound in 27% yield; NMR spectrum (DMSO-d6) 1.37 (d, 3H), 2.06 (s, 6H), 3.08 (s, 3H), 3.23 (dd, 1H), 3.25 (s, 2H), 4.26 (dd, 1H), 5.10 (m, 1H), 5.29 (s, 2H), 7.23 (m, 2H), 7.30 (d, 1H), 7.35 (m, 1H), 7.56 (s, 1H), 7.68 (m, 2H), 7.87 (dt, 1H), 8.13 (d, 1H), 8.44 (s, 1H), 8.58 (d, 1H), 9.90 (s, 1H); Mass Spectrum MH+ 535.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07625908B2uspto-grants-2009_12